We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

This study has been terminated.
(Study terminated due to an unexpected prominent effect of entecavir alone in this patient population.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01217632
First Posted: October 8, 2010
Last Update Posted: August 16, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
FibroGen
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)

To Top